At the beginning of August, the European Medicines Agency (EMA) published a report on a pilot project of a new accelerated path for drug approval (adaptive pathways). In this approval procedure, for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback